Inflammatory Responses, Spirometry, and Quality of Life in Subjects With Bronchiectasis Exacerbations.

BACKGROUND: Bronchiectasis exacerbations are critical events characterized by worsened symptoms and signs (ie, cough frequency, sputum volume, malaise). Objectives: Our goal was to examine variations in airway and systemic inflammation, spirometry, and quality of life during steady state, bronchiect...

Full description

Bibliographic Details
Published in:Respiratory Care Vol. 60; no. 8; pp. 1180 - 1190
Main Authors: Wei-jie Guan, Yong-hua Gao, Gang Xu, Zhi-ya Lin, Yan Tang, Hui-min Li, Zhi-min Lin, Mei Jiang, Jin-ping Zheng, Rong-chang Chen, Nan-shan Zhong
Format: research tables/charts Journal Article
Published: Mary Ann Liebert, Inc. Aug2015
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=109826264&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 109826264
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00201324
        4GG
      jtl: Respiratory Care
      issn: 00201324
      maglogo: N
    pubinfo:
      dt: Aug2015
      vid: 60
      iid: 8
      pid: 1365
      pub: Mary Ann Liebert, Inc.
      place: New Rochelle, New York
    artinfo:
      ui:
        109826264
        108735523
        10.4187/respcare.04004
        NLM26060319
        109826264
      ppf: 1180
      ppct: 10
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Inflammatory Responses, Spirometry, and Quality of Life in Subjects With Bronchiectasis Exacerbations.
      aug:
        au:
          Wei-jie Guan
          Yong-hua Gao
          Gang Xu
          Zhi-ya Lin
          Yan Tang
          Hui-min Li
          Zhi-min Lin
          Mei Jiang
          Jin-ping Zheng
          Rong-chang Chen
          Nan-shan Zhong
        affil: State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China
      sug:
        subj:
          Bronchiectasis Physiopathology
          Disease Exacerbation Physiopathology
          Recovery Immunology
          Quality of Life
          Bacterial Infections
          Biological Markers
          Spirometry
          Human
          Sputum Analysis
          Blood Analysis
          Questionnaires
          Descriptive Statistics
          Adult
          Middle Age
          Forced Expiratory Volume
          Forced Expiratory Flow Rates
          Funding Source
          Female
          Male
          C-Reactive Protein Blood
          Data Analysis Software
          Chi Square Test
          T-Tests
          One-Way Analysis of Variance
          Kruskal-Wallis Test
          Antibiotics Therapeutic Use
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Female
          Male
      ab: BACKGROUND: Bronchiectasis exacerbations are critical events characterized by worsened symptoms and signs (ie, cough frequency, sputum volume, malaise). Objectives: Our goal was to examine variations in airway and systemic inflammation, spirometry, and quality of life during steady state, bronchiectasis exacerbations, and convalescence (1 week following a 2-week antibiotic treatment) to determine whether potentially pathogenic microorganisms, including Pseudomonas aeruginosa, were associated with poorer conditions during bronchiectasis exacerbations. METHODS: Peripheral blood and sputum were sampled to detect inflammatory mediators and bacterial densities. Spirometry and quality of life (St George Respiratory Questionnaire [SGRQ]) were assessed during the 3 stages. RESULTS: Forty-eight subjects with bronchiectasis (43.2 ± 14.2 y of age) were analyzed. No notable differences in species and density of potentially pathogenic microorganisms were found during bronchiectasis exacerbations. Except for CXCL8 and tumor necrosis factor alpha (TNF-a), serum inflammation was heightened during bronchiectasis exacerbations and recovered during convalescence. Even though sputum TNF-a was markedly higher during bronchiectasis exacerbations and remained heightened during convalescence, the variations in miscellaneous sputum markers were unremarkable. Bronchiectasis exacerbations were associated with notably higher SGRQ symptom and total scores, which recovered during convalescence. FVC, FEV!, and maximum mid-expiratory flow worsened during bronchiectasis exacerbations (median change from baseline of -2.2%, -0.8%, and -1.3%) and recovered during convalescence (median change from baseline of 0.6%, 0.7%, and -0.7%). Compared with no bacterial isolation, potentially pathogenic microorganism or P. aeruginosa isolation at baseline did not result in poorer clinical condition during bronchiectasis exacerbations. CONCLUSIONS: Bronchiectasis exacerbations are characterized by heightened inflammatory responses and poorer quality of life and spirometry, but not by increased bacterial density, which applies for subjects with and without potentially pathogenic microorganism isolation when clinically stable. (CIinicalTrials.gov registration NCT01761214.)
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N